{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-197971","form_type":"8-K","ticker":"NAMS","cik":"0001936258","company_name":"NewAmsterdam Pharma Co N.V.","filed_at":"2024-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.230804+00:00","generated_at":"2026-05-31T10:33:15.130979+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"NewAmsterdam Pharma enters $150M ATM equity offering with TD Cowen as agent","bullets":["Amended Sales Agreement replaces Cowen and Company with TD Cowen as sole sales agent.","Company may issue and sell up to $150M in ordinary shares at market prices via ATM offering.","No shares were sold under the prior December 2023 sales agreement.","TD Cowen receives up to 3% commission on gross sales; company has no obligation to sell.","Sales may be made through an affiliate of TD Cowen; agreement terminable at will by either party."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-197971","json":"https://secwatch.observer/filing/0001193125-24-197971.json","markdown":"https://secwatch.observer/filing/0001193125-24-197971.md","text":"https://secwatch.observer/filing/0001193125-24-197971.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1936258/000119312524197971/0001193125-24-197971-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1936258/000119312524197971/d823291d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:33:15.130979+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}